Risk for intravesical recurrence of bladder cancer stratified by the results on two consecutive UroVysion fluorescence in situ hybridization tests: a prospective follow-up study in Japan.

MLA

Ikeda, Atsushi, et al. “Risk for Intravesical Recurrence of Bladder Cancer Stratified by the Results on Two Consecutive UroVysion Fluorescence in Situ Hybridization Tests: A Prospective Follow-up Study in Japan.” International Journal of Clinical Oncology, vol. 25, no. 6, June 2020, pp. 1163–69. EBSCOhost, https://doi.org/10.1007/s10147-020-01634-9.

APA

Ikeda, A., Kojima, T., Kawai, K., Hinotsu, S., Keino, N., Shiga, K., Miyake, H., Miyata, Y., Enomoto, Y., Shimizu, F., Anai, S., Matsuyama, H., Suzuki, C., Kanimoto, Y., Shigeta, K., Naito, S., Akaza, H., & Nishiyama, H. (2020). Risk for intravesical recurrence of bladder cancer stratified by the results on two consecutive UroVysion fluorescence in situ hybridization tests: a prospective follow-up study in Japan. International Journal of Clinical Oncology, 25(6), 1163–1169. https://doi.org/10.1007/s10147-020-01634-9

Chicago

Ikeda, Atsushi, Takahiro Kojima, Koji Kawai, Shiro Hinotsu, Naoto Keino, Kenichiro Shiga, Hideaki Miyake, et al. 2020. “Risk for Intravesical Recurrence of Bladder Cancer Stratified by the Results on Two Consecutive UroVysion Fluorescence in Situ Hybridization Tests: A Prospective Follow-up Study in Japan.” International Journal of Clinical Oncology 25 (6): 1163–69. doi:10.1007/s10147-020-01634-9.